The variability of the apnea-hypopnea index(AHI) measured in the first and second halves of the night is significant in patients with obstructive sleep apnea hypopnea syndrome(OSAHS). This variation may be related to fluid redistribution caused by the supine position during sleep. Eighty-nine adult subjects were enrolled. Circumferences(neck, chest, waist, and calf) were measured before sleep onset and upon awakening. Polysomnography(PSG) was performed, and the night was divided into two halves based on the midpoint of total sleep time to calculate AHI for each half. The correlation between changes in AHI and changes in circumferences was analyzed. Twenty simple snorers and sixty-nine OSAHS patients were included, with a median AHI of 22.6(11.8, 47.3) events/hour. Compared to pre-sleep measurements, there was no significant change in neck circumference upon awakening in the control group(=0.073), while reductions were observed in the other three measurements(=0.006, =0.038, <0.001). In the OSAHS group, neck circumference increased(<0.001), and reductions were noted in the other three measurements(<0.001 for all), with the most significant change observed in calf circumference 40.0(37.1, 42.0) cm to 38.0(35.8, 40.5) cm. Compared to the first half of the night, total AHI, supine AHI, and NREM AHI significantly decreased in the second half(=0.010, =0.031, =0.001), while no significant changes were observed in lateral AHI and REM AHI(=0.988, =0.530). Further analysis revealed a significant relationship between increased chest circumference and decreases in NREM AHI, supine AHI, and supine NREM AHI(=0.036, =0.072, =0.034), as well as between decreased lateral position AHI and increased waist circumference(=0.048). Additionally, this study found a negative correlation between changes in calf circumference and changes in AHI(=-0.24, =0.048), while neck circumference changes positively correlated with changes in AHI(=0.26, =0.03). In OSAHS patients during the second half of sleep compared to before sleeping, chest circumference, waist circumference, and calf circumference decrease while neck circumference increases; total AHI, supine position AHI, and NREM period AHI decrease; increases in chest circumference are associated with decreases in NREM period AHI, supine position AHI, supine position NREM period AHI. There is nocturnal variability in AHI among OSAHS patients that may be associated with fluid shifts during sleep.

Download full-text PDF

Source
http://dx.doi.org/10.13201/j.issn.2096-7993.2025.01.009DOI Listing

Publication Analysis

Top Keywords

obstructive sleep
8
sleep apnea
8
sleep
5
[factors influencing
4
influencing severity
4
severity variability
4
variability obstructive
4
apnea role
4
role fluid
4
fluid shift]
4

Similar Publications

The Rise of Type 2 Diabetes in Children and Adolescents: An Emerging Pandemic.

Diabetes Metab Res Rev

January 2025

Department of Human Genetics, Guru Nanak Dev University, Amritsar, India.

Aim: This review explores the increasing prevalence of Type 2 Diabetes Mellitus (T2DM) in children and adolescents, focusing on its etiology, risk factors, complications, and the importance of early detection and management. It also highlights the need for a multidisciplinary, family-centered approach in managing T2DM in pediatric populations, with an emphasis on nutrition, exercise, and lifestyle interventions.

Materials And Methods: A literature review was conducted using PubMed, Google Scholar, and Scopus to incorporate studies from 2015 to 2024 on T2DM in youths/adolescents/children, focusing on epidemiology, risk factors, and prevention strategies.

View Article and Find Full Text PDF

Multimodal sleep staging network based on obstructive sleep apnea.

Front Comput Neurosci

December 2024

School of Electrical and Electronic Engineering, Chongqing University of Technology, Chongqing, China.

Background: Automatic sleep staging is essential for assessing sleep quality and diagnosing sleep disorders. While previous research has achieved high classification performance, most current sleep staging networks have only been validated in healthy populations, ignoring the impact of Obstructive Sleep Apnea (OSA) on sleep stage classification. In addition, it remains challenging to effectively improve the fine-grained detection of polysomnography (PSG) and capture multi-scale transitions between sleep stages.

View Article and Find Full Text PDF

Polysomnographic Phenotype of Positional Obstructive Sleep Apnea.

J Rhinol

November 2024

Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Background And Objectives: Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by recurrent upper airway obstruction, leading to disrupted sleep and various health complications. Positional OSA (POSA) refers to patients whose OSA severity is significantly influenced by body position, especially when lying supine. This study aimed to evaluate the polysomnographic characteristics of POSA and non-positional OSA (non-POSA) and to assess their clinical implications.

View Article and Find Full Text PDF

Background: Sleep-disordered breathing (SDB) impairs exercise capacity after myocardial infarction (MI).

Aims: This study aimed to evaluate the impact of SDB on the efficacy of post-MI cardiac rehabilitation (CR).

Methods: The study evaluated consecutive patients up to 28 days after MI who participated in outpatient CR as part of the Polish Managed Care after Acute Myocardial Infarction program.

View Article and Find Full Text PDF

The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) in the same patient is referred to as overlap syndrome (OS). Patients with OS suffer more frequently from cardiovascular disease (CVD) and carry a higher risk of COPD-related exacerbations than patients with COPD alone, especially when OSA is left untreated. Based on recent evidence, triple therapy, namely inhaled corticosteroid/long-acting muscarinic antagonist/long-acting beta-agonist (ICS-LABA-LAMA), is a treatment strategy in COPD patients with a history of exacerbations and/or CVD comorbidity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!